Winner Medical Co Ltd
300888.SHE
Exchange: | SHE |
Currency | Renminbi |
ISIN: | CNE1000047Z8 |
Primary Ticker: | 300888.SHE |
Fiscal Year End: | December |
Sector: | Healthcare |
Industry: | Medical Instruments & Supplies |
Gic Sector: | Health Care |
Gic Group: | Health Care Equipment & Services |
Gic Industry: | Health Care Equipment & Supplies |
Gic Sub Industry: | Health Care Equipment |
Description: | Winner Medical Co., Ltd. engages in the research and development, manufacture, and marketing of cotton-based medical dressings and medical disposables, and consumer products in China. It offers wound care products, including gauze, bandages, adhesive and film dressing, cotton and non-woven products, liquid skin protectants, debridement, exudate management, anti-adhesive wound care, scar repair, antimicrobial, collagen dressing, and compression treatment products, as well as wound care, dressing change, suture and remove, catheter, disinfection, anesthesia kits; and masks, gloves, protective apparel, disinfection products, surgical gowns and drapes, specialty drapes and packs, OR solution accessories, general surgical kits and trays, and pet care solutions. The company also provides adult diapers, incontinence nursing pads, cotton balls and swabs, foot care products, hand sanitizers, facial and lens cleansing wipes, sports care and hygiene products, wipes, and cosmetic and other cotton products. It provides its products under the Winner Medical, Purcotton, and Pure H2B brands for hospitals, pharmacy, PPE, consumer, and industrial fields. Winner Medical Co., Ltd. was founded in 1991 and is based in Shenzhen, China. Winner Medical Co., Ltd. is a subsidiary of Winner Group Limited. |
Address: | Building No.2, Huilong Business Center, Shenzhen, China, 518131 |
Website: | https://www.winnermedical.com |
Full Time Employees: | 13014 |
Updated On: | 2024-11-02 |
Highlights
Market Capitalization: | 18558857216 |
Market Capitalization Mln: | 18558.85 |
EBITDA: | 766704320 |
Wall Street Target Price: | 41.65 |
Book Value: | 19.71 |
Dividend Share: | 0.9 |
Dividend Yield: | 0.02 |
Earnings Share: | -1.72 |
Most Recent Quarter: | 2024-06-30 |
Profit Margin: | -0.12 |
Operating Margin TTM: | 0.12 |
Return On Assets TTM: | 0.01 |
Return On Equity TTM: | -0.07 |
Revenue TTM: | 8244622336 |
Revenue Per Share TTM: | 14.03 |
Quarterly Revenue Growth YOY: | 0.16 |
Gross Profit TTM: | 5378530728 |
Diluted Eps TTM: | -1.72 |
Quarterly Earnings Growth YOY: | -0.88 |
Valuation
Price Sales TTM: | 2.36 |
Price Book MRQ: | 1.63 |
Enterprise Value: | 15513468437 |
Enterprise Value Revenue: | 1.88 |
Enterprise Value Ebitda: | 9.64 |
Shares
Shares Outstanding: | 582329984 |
Shares Float: | 141039510 |
Percent Insiders: | 78.21 |
Percent Institutions: | 3.24 |
Technicals
Beta: | 0.51 |
52 Week High: | 39.53 |
52 Week Low: | 22.98 |
50 Day MA: | 27.18 |
200 Day MA: | 30.34 |
Splits & Dividends
Forward Annual Dividend Rate: | 0.9 |
Forward Annual Dividend Yield: | 0.02 |
Payout Ratio: | 0.94 |
Ex Dividend Date: | 2024-09-30 |
Last Split Factor: | 1.4:1 |
Last Split Date: | 2023-06-02 |
Earnings
Report Date: | 2025-05-21 |
Date: | 2025-03-31 |
Before After Market: | After Market |
Currency: | CNY |
Report Date: | 2024-10-28 |
Date: | 2024-09-30 |
Before After Market: | After Market |
Currency: | CNY |
Eps Actual: | 0.28 |
Report Date: | 2024-08-28 |
Date: | 2024-06-30 |
Currency: | CNY |
Eps Actual: | 0.34 |
Report Date: | 2024-04-24 |
Date: | 2024-03-31 |
Before After Market: | After Market |
Currency: | CNY |
Eps Actual: | 0.31 |
Report Date: | 2023-10-23 |
Date: | 2023-09-30 |
Before After Market: | After Market |
Currency: | CNY |
Eps Actual: | 2.50 |
Report Date: | 2023-08-15 |
Date: | 2023-06-30 |
Before After Market: | After Market |
Currency: | CNY |
Eps Actual: | 0.52 |
Report Date: | 2023-04-24 |
Date: | 2023-03-31 |
Before After Market: | After Market |
Currency: | CNY |
Eps Actual: | 0.89 |
Report Date: | 2022-10-24 |
Date: | 2022-09-30 |
Before After Market: | After Market |
Currency: | CNY |
Eps Actual: | 0.85 |
Report Date: | 2022-08-17 |
Date: | 2022-06-30 |
Before After Market: | After Market |
Currency: | CNY |
Eps Actual: | 1.28 |
Report Date: | 2022-04-21 |
Date: | 2022-03-31 |
Before After Market: | After Market |
Currency: | CNY |
Eps Actual: | 0.84 |
Report Date: | 2021-10-25 |
Date: | 2021-09-30 |
Before After Market: | After Market |
Currency: | CNY |
Eps Actual: | 0.8 |
Report Date: | 2021-08-20 |
Date: | 2021-06-30 |
Before After Market: | After Market |
Currency: | CNY |
Eps Actual: | 0.66 |
Report Date: | 2021-04-20 |
Date: | 2021-03-31 |
Before After Market: | After Market |
Currency: | CNY |
Eps Actual: | 1.12 |
Report Date: | 2020-10-28 |
Date: | 2020-09-30 |
Before After Market: | Before Market |
Currency: | CNY |
Eps Actual: | 4.96 |
Date: | 2023-12-31 |
Period: | +1y |
Growth: | -0.29 |
Earnings Estimate Year Ago Eps: | 3.94 |
Earnings Estimate Growth: | -0.29 |
Revenue Estimate Avg: | 8185020000.00 |
Revenue Estimate Low: | 8150000000.00 |
Revenue Estimate High: | 10125000000.00 |
Revenue Estimate Number Of Analysts: | 9.00 |
Revenue Estimate Growth: | -0.27 |
Eps Trend7days Ago: | 2.67 |
Eps Trend30days Ago: | 2.67 |
Eps Trend60days Ago: | 2.67 |
Eps Trend90days Ago: | 2.67 |
Date: | 2023-03-31 |
Period: | +1q |
Date: | 2022-12-31 |
Growth: | 0.89 |
Earnings Estimate Year Ago Eps: | 2.08 |
Earnings Estimate Growth: | 0.89 |
Revenue Estimate Avg: | 11351300000.00 |
Revenue Estimate Low: | 9928000000.00 |
Revenue Estimate High: | 11478000000.00 |
Revenue Estimate Number Of Analysts: | 10.00 |
Revenue Estimate Growth: | 0.41 |
Eps Trend7days Ago: | 3.94 |
Eps Trend30days Ago: | 3.94 |
Eps Trend60days Ago: | 3.94 |
Eps Trend90days Ago: | 3.94 |
Date: | 2024-09-30 |
Eps Actual: | 15.39 |